NYSE:TGX - Theragenics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0050 0.00 (0.00 %) (As of 08/19/2018 03:31 PM ET)Previous Close$0.0050Today's Range$0.0050 - $0.005052-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileChartEarnings HistoryFinancialsHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two business segments: surgical products segment and brachytherapy seed segment. The Company's surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. The Company's brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs , manufactures, assembles, packages and distributes its surgical products in three primary production facilities, each of which manufactures different products. In October 2013, the Company announced that it has completed the merger with Juniper Acquisition Corporation. Receive TGX News and Ratings via Email Sign-up to receive the latest news and ratings for TGX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryN/A SectorN/A SymbolNYSE:TGX CUSIPN/A Webwww.theragenics.com Phone+1-770-8315137 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$0.00 Theragenics (NYSE:TGX) Frequently Asked Questions What is Theragenics' stock symbol? Theragenics trades on the New York Stock Exchange (NYSE) under the ticker symbol "TGX." Has Theragenics been receiving favorable news coverage? Media headlines about TGX stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Theragenics earned a media and rumor sentiment score of 0.11 on Accern's scale. They also assigned media stories about the medical device company an impact score of 46.87 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future. View Recent Headlines for Theragenics. How do I buy shares of Theragenics? Shares of TGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Theragenics' stock price today? One share of TGX stock can currently be purchased for approximately $0.0050. How can I contact Theragenics? Theragenics' mailing address is 5203 Bristol Industrial Way, BUFORD, GA 30518, United States. The medical device company can be reached via phone at +1-770-8315137. MarketBeat Community Rating for Theragenics (NYSE TGX)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 33 (Vote Outperform)Underperform Votes: 34 (Vote Underperform)Total Votes: 67MarketBeat's community ratings are surveys of what our community members think about Theragenics and other stocks. Vote "Outperform" if you believe TGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TGX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/19/2018 by MarketBeat.com StaffFeatured Article: How are Outstanding Shares Different from Authorized Shares?